These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20627789)

  • 1. Treatment of inflammatory muscle disease in adults.
    Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):390-4. PubMed ID: 20627789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of polymyositis and dermatomyositis.
    Marie I
    Presse Med; 2011 Apr; 40(4 Pt 2):e257-70. PubMed ID: 21334847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab and mycophenolate combination therapy in refractory dermatomyositis with multiple autoimmune disorders.
    Parziale N; Kovacs SC; Thomas CB; Srinivasan J
    J Clin Neuromuscul Dis; 2011 Dec; 13(2):63-7. PubMed ID: 22361690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the inflammatory myopathies: update and practical recommendations.
    Hengstman GJ; van den Hoogen FH; van Engelen BG
    Expert Opin Pharmacother; 2009 May; 10(7):1183-90. PubMed ID: 19405792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of myositis].
    Keck AD; Walker UA
    Z Rheumatol; 2013 Apr; 72(3):227-35. PubMed ID: 23456367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.
    Sharma AP; Filler G
    Pediatr Nephrol; 2009 Feb; 24(2):423-4. PubMed ID: 18853197
    [No Abstract]   [Full Text] [Related]  

  • 17. Current diagnosis and treatment of polymyositis and dermatomyositis.
    Sasaki H; Kohsaka H
    Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
    O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
    Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials roundup in idiopathic inflammatory myopathies.
    Mann HF; Vencovský J
    Curr Opin Rheumatol; 2011 Nov; 23(6):605-11. PubMed ID: 21926626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches in myositis.
    Aggarwal R; Oddis CV
    Curr Rheumatol Rep; 2011 Jun; 13(3):182-91. PubMed ID: 21365210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.